AI-based smartphone apps for risk assessment of skin cancer need more evaluation and better regulation
- 19 March 2021
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 124 (11) , 1749-1750
Abstract
Smartphone applications (“apps”) with artificial intelligence (AI) algorithms are increasingly used in healthcare. Widespread adoption of these apps must be supported by a robust evidence-base and app manufacturers’ claims appropriately regulated. Current CE marking assessment processes inadequately protect the public against the risks created by using smartphone diagnostic apps.Keywords
Funding Information
- DH | National Institute for Health Research (BRC-1215-20009)
This publication has 6 references indexed in Scilit:
- Sensitivity and specificity of SkinVision are likely to have been overestimatedJournal of the European Academy of Dermatology and Venereology, 2020
- Algorithm based smartphone apps to assess risk of skin cancer in adults: systematic review of diagnostic accuracy studiesBMJ, 2020
- Accuracy of a smartphone application for triage of skin lesions based on machine learning algorithmsJournal of the European Academy of Dermatology and Venereology, 2019
- A Hierarchical Framework for Evaluation and Informed Decision Making Regarding Smartphone Apps for Clinical CarePsychiatric Services, 2018
- Growth of mobile applications in dermatology - 2017 updateDermatology Online Journal, 2018
- Many Mobile Health Apps Target High-Need, High-Cost Populations, But Gaps RemainHealth Affairs, 2016